COVID-19 Monoclonal Antibody Infusion Center: Information for Patients

Please Note: Currently, only one available monoclonal infusion medication (Sotrovimab) is effective against the omicron variant of COVID-19. It is in very low supply and available only to patients who meet certain criteria. We must prioritize patients based on these factors. We are no longer scheduling appointments for Regeneron therapy.

Evusheld therapy is currently available as preventative treatment for patients who are immunocompromised or unable to receive a COVID-19 vaccine due to severe adverse reactions. It is not a treatment for existing COVID-19 infection. Due to low availability, we must prioritize eligible patients seeking treatment with Evusheld.

Monoclonal antibody treatment must be administered within 7 days of COVID-19 symptoms starting.

Who is Eligible for COVID-19 Monoclonal Antibody Treatment at MUSC Health?

Monoclonal antibody infusion for COVID-19 infection is available for those who have COVID-19 and

  • Are high risk for developing severe COVID-19 and
  • Have a positive COVID-19 test and have not yet been admitted to the hospital and
  • Are 12 years of age or older (and at least 88 pounds)

"High Risk" is defined as those who are/have any of the following:

  • 65 years of age or older
  • Overweight (body mass index over 25)
  • Pregnant
  • Chronic kidney disease
  • Diabetes (Type 1 and Type 2)
  • Weakened immune system
  • Currently receiving immunosuppressive treatment
  • Cardiovascular disease/hypertension
  • Chronic lung disease
  • Sickle cell disease
  • Neurodevelopmental disorders
  • Medical-related technological dependence

How Can Patients Schedule an Appointment to Receive Antibody Infusion Treatment?

In order to obtain an appointment for COVID-19 antibody infusion treatment, patients who meet the above criteria must have a referral from their provider. Patients will be contacted directly by MUSC Health after the referral is received and processed.

Important: Currently, only one available monoclonal infusion medication (Sotrovimab) is effective against the omicron variant of COVID-19. Because it is in very low supply throughout the country and available only to patients who meet specific criteria, we must prioritize patients for its use until more becomes available. We are no longer scheduling appointments for Regeneron therapy. If you have questions about your COVID-19 treatment options, please contact your primary care provider.

How To Get a Referral

A referral can be obtained by any of the following methods:

Additional Information for Patients